17 employees
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.
2020
$27M
from 2 investors over 2 rounds
RNAimmune raised $27M on March 29, 2022
Investors: Sirnaomics, Inc.
RNAimmune raised $10M on April 21, 2021